BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 19770585)

  • 1. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.
    Heddleston JM; Li Z; McLendon RE; Hjelmeland AB; Rich JN
    Cell Cycle; 2009 Oct; 8(20):3274-84. PubMed ID: 19770585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidic stress promotes a glioma stem cell phenotype.
    Hjelmeland AB; Wu Q; Heddleston JM; Choudhary GS; MacSwords J; Lathia JD; McLendon R; Lindner D; Sloan A; Rich JN
    Cell Death Differ; 2011 May; 18(5):829-40. PubMed ID: 21127501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.
    Li Y; Li A; Glas M; Lal B; Ying M; Sang Y; Xia S; Trageser D; Guerrero-Cázares H; Eberhart CG; Quiñones-Hinojosa A; Scheffler B; Laterra J
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9951-6. PubMed ID: 21628563
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Das B; Pal B; Bhuyan R; Li H; Sarma A; Gayan S; Talukdar J; Sandhya S; Bhuyan S; Gogoi G; Gouw AM; Baishya D; Gotlib JR; Kataki AC; Felsher DW
    Cancer Res; 2019 Aug; 79(16):4015-4025. PubMed ID: 31266772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions.
    Wang P; Yan Q; Liao B; Zhao L; Xiong S; Wang J; Zou D; Pan J; Wu L; Deng Y; Wu N; Gong S
    Cell Death Dis; 2020 Nov; 11(11):992. PubMed ID: 33208727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.
    Li Z; Bao S; Wu Q; Wang H; Eyler C; Sathornsumetee S; Shi Q; Cao Y; Lathia J; McLendon RE; Hjelmeland AB; Rich JN
    Cancer Cell; 2009 Jun; 15(6):501-13. PubMed ID: 19477429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia and hypoxia inducible factors in cancer stem cell maintenance.
    Li Z; Rich JN
    Curr Top Microbiol Immunol; 2010; 345():21-30. PubMed ID: 20582533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor.
    Liu TZ; Wang X; Bai YF; Liao HZ; Qiu SC; Yang YQ; Yan XH; Chen J; Guo HB; Zhang SZ
    Int J Biochem Cell Biol; 2014 Apr; 49():8-16. PubMed ID: 24434023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status.
    Moreno-Manzano V; Rodríguez-Jiménez FJ; Aceña-Bonilla JL; Fustero-Lardíes S; Erceg S; Dopazo J; Montaner D; Stojkovic M; Sánchez-Puelles JM
    J Biol Chem; 2010 Jan; 285(2):1333-42. PubMed ID: 19897487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
    Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
    Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF2α Upregulates the Migration Factor ODZ1 under Hypoxia in Glioblastoma Stem Cells.
    Carcelén M; Velásquez C; Vidal V; Gutierrez O; Fernandez-Luna JL
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054927
    [No Abstract]   [Full Text] [Related]  

  • 13. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
    Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
    Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy.
    Kwak JH; Lee NH; Lee HY; Hong IS; Nam JS
    Oncotarget; 2016 Jul; 7(28):43518-43533. PubMed ID: 27270657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.
    Schöning JP; Monteiro M; Gu W
    Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypoxia-inducible factors HIF1α and HIF2α are dispensable for embryonic muscle development but essential for postnatal muscle regeneration.
    Yang X; Yang S; Wang C; Kuang S
    J Biol Chem; 2017 Apr; 292(14):5981-5991. PubMed ID: 28232488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells.
    Johansson E; Grassi ES; Pantazopoulou V; Tong B; Lindgren D; Berg TJ; Pietras EJ; Axelson H; Pietras A
    Cell Rep; 2017 Aug; 20(7):1641-1653. PubMed ID: 28813675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF1α and HIF2α regulate non-small-cell lung cancer dedifferentiation via expression of Sox2 and Oct4 under hypoxic conditions.
    Xiong S; Wang D; Tang Y; Lu S; Huang L; Wu Z; Lei S; Liang G; Yang D; Li D; Li Y
    Gene; 2023 May; 863():147288. PubMed ID: 36804853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors.
    Mao XG; Yan M; Xue XY; Zhang X; Ren HG; Guo G; Wang P; Zhang W; Huo JL
    Lab Invest; 2011 Jul; 91(7):1068-78. PubMed ID: 21483406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell metabolism under microenvironmental low oxygen tension levels in stemness, proliferation and pluripotency.
    De Miguel MP; Alcaina Y; de la Maza DS; Lopez-Iglesias P
    Curr Mol Med; 2015; 15(4):343-59. PubMed ID: 25941818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.